Magnetic resonance imaging of malignant soft tissue neoplasms in the adult

Radiologic Clinics of North America

Volumn 49, Issue 6, 2011, Pages 1219-1234

  Walker, Eric A ^a,b   Salesky, Joel S ^c   Fenton, Michael E ^c   Murphey, Mark D ^b,c,d  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c American Institute for Radiologic Pathology   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Malignant; MR imaging; Soft tissue neoplasm; Soft tissue tumor

Indexed keywords

ADULT; ANGIOSARCOMA; CANCER GRADING; CANCER LOCALIZATION; CLEAR CELL SARCOMA; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; HEMANGIOENDOTHELIOMA; HEMANGIOPERICYTOMA; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LEIOMYOSARCOMA; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT TRANSFORMATION; MOLECULAR PATHOLOGY; MYXOSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEX RATIO; SKIN CARCINOGENESIS; SOFT TISSUE CANCER; SYNOVIAL SARCOMA; TUMOR DIFFERENTIATION;

ADULT; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; HEMANGIOENDOTHELIOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NERVE SHEATH NEOPLASMS; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 82455168261     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2011.07.006     Document Type: Review

References (99)

1. Hajdu S.I. Soft tissue sarcomas: classification and natural history. CA Cancer J Clin 1981, 31(5):271-280.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
3. Walker E.A., Song A.J., Murphey M.D. Magnetic resonance imaging of soft-tissue masses. Semin Roentgenol 2010, 45(4):277-297.
4. Baldursson G., Agnarsson B.A., Benediktsdottir K.R., et al. Soft tissue sarcomas in Iceland 1955-1988. Analysis of survival and prognostic factors. Acta Oncol 1991, 30(5):563-568.
5. Rydholm A. Management of patients with soft-tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand Suppl 1983, 203:13-77.
6. Ma L.D., Frassica F.J., McCarthy E.F., et al. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Radiology 1997, 202(3):739-744.
7. Benedikt R.A., Jelinek J.S., Kransdorf M.J., et al. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine. J Magn Reson Imaging 1994, 4(3):485-490.
8. Erlemann R., Reiser M.F., Peters P.E., et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989, 171(3):767-773.
9. Beltran J., Chandnani V., McGhee R.A., et al. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system. AJR Am J Roentgenol 1991, 156(3):457-466.
10. van Rijswijk C.S., Geirnaerdt M.J., Hogendoorn P.C., et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 2004, 233(2):493-502.
11. Mirowitz S.A., Totty W.G., Lee J.K. Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI. J Comput Assist Tomogr 1992, 16(1):120-125.
12. Berquist T.H., Ehman R.L., King B.F., et al. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR Am J Roentgenol 1990, 155(6):1251-1255.
13. Crim J.R., Seeger L.L., Yao L., et al. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?. Radiology 1992, 185(2):581-586.
14. Kransdorf M.J., Jelinek J.S., Moser R.P., et al. Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 1989, 153(3):541-547.
15. Murphey MD, Nomikos GC. Prospective diagnosis Q12 of soft tissue tumors. Presentation at the RSNA in 2001;221:473.
16. Mankin H.J., Lange T.A., Spanier S.S. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982, 64(8):1121-1127.
17. Mankin H.J., Mankin C.J., Simon M.A. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996, 78(5):656-663.
18. Sundaram M., McGuire M.H., Herbold D.R. Magnetic resonance imaging of soft tissue masses: an evaluation of fifty-three histologically proven tumors. Magn Reson Imaging 1988, 6(3):237-248.
19. Moulton J.S., Blebea J.S., Dunco D.M., et al. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR Am J Roentgenol 1995, 164(5):1191-1199.
20. Totty W.G., Murphy W.A., Lee J.K. Soft-tissue tumors: MR imaging. Radiology 1986, 160(1):135-141.
21. Peabody T.D., Simon M.A. Principles of staging of soft-tissue sarcomas. Clin Orthop Relat Res 1993, (289):19-31.
22. Myhre-Jensen O. A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand 1981, 52(3):287-293.
23. Kransdorf M.J. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995, 164(1):129-134.
24. Connelly J.H., Evans H.L. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 1992, 16(10):921-925.
25. Ding J., Hashimoto H., Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors. Cancer 1989, 64(3):721-729.
26. Wrotnowski U., Cooper P.H., Shmookler B.M. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol 1988, 12(4):287-293.
27. Taylor H.B., Helwig E.B. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962, 15:717-725.
28. Thornton S.L., Reid J., Papay F.A., et al. Childhood dermatofibrosarcoma protuberans: role of preoperative imaging. J Am Acad Dermatol 2005, 53(1):76-83.
29. Weiss S.W., Goldblum J.R., Enzinger F.M. Fibrohistiocytic tumors of intermediate malignancy. Enzinger and Weiss' soft tissue tumors 2008, 371-402. Mosby Elsevier, Philadelphia. 5th edition. S.W. Weiss, J.R. Goldblum (Eds.).
30. Roses D.F., Valensi Q., LaTrenta G., et al. Surgical treatment of dermatofibrosarcoma protuberans. Surg Gynecol Obstet 1986, 162(5):449-452.
31. Rockley P.F., Robinson J.K., Magid M., et al. Dermatofibrosarcoma protuberans of the scalp: a series of cases. J Am Acad Dermatol 1989, 21(2 Pt 1):278-283.
32. McPeak C.J., Cruz T., Nicastri A.D. Dermatofibrosarcoma protuberans: an analysis of 86 cases-five with metastasis. Ann Surg 1967, 166(5):803-816.
33. Kransdorf M.J., Murphey M.D. Imaging of soft tissue tumors 2006, Lippincott Williams & Wilkins, Philadelphia. 2nd edition.
34. Murphey M.D. World Health Organization classification of bone and soft tissue tumors: modifications and implications for radiologists. Semin Musculoskelet Radiol 2007, 11(3):201-214.
35. Pritchard D.J., Sim F.H., Ivins J.C., et al. Fibrosarcoma of bone and soft tissues of the trunk and extremities. Orthop Clin North Am 1977, 8(4):869-881.
36. Pritchard D.J., Soule E.H., Taylor W.F., et al. Fibrosarcoma-a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer 1974, 33(3):888-897.
37. Scott S.M., Reiman H.M., Pritchard D.J., et al. Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases. Cancer 1989, 64(4):925-931.
38. Ninane J., Gosseye S., Panteon E., et al. Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery. Cancer 1986, 58(7):1400-1406.
39. Weiss S.W., Enzinger F.M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978, 41(6):2250-2266.
40. Weiss S.W., Goldblum J.R., Enzinger F.M. Malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma). Enzinger and Weiss' soft tissue tumors 2008, 403-426. Mosby Elsevier, Philadelphia. 5th edition. S.W. Weiss, J.R. Goldblum (Eds.).
41. Laskin W.B., Silverman T.A., Enzinger F.M. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer 1988, 62(11):2330-2340.
42. Fletcher C.D.M., Unni K.K., Mertens F. World Health Organization Pathology and Genetics of tumors of soft tissue and bone 2006, IARC Press, Lyon (France). 3rd edition.
43. Murphey M.D., Gross T.M., Rosenthal H.G. From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation. Radiographics 1994, 14(4):807-826. [quiz: 827-8].
44. Mahajan H., Kim E.E., Wallace S., et al. Magnetic resonance imaging of malignant fibrous histiocytoma. Magn Reson Imaging 1989, 7(3):283-288.
45. Miller T.T., Hermann G., Abdelwahab I.F., et al. MRI of malignant fibrous histiocytoma of soft tissue: analysis of 13 cases with pathologic correlation. Skeletal Radiol 1994, 23(4):271-275.
46. Panicek D.M., Casper E.S., Brennan M.F., et al. Hemorrhage simulating tumor growth in malignant fibrous histiocytoma at MR imaging. Radiology 1991, 181(2):398-400.
47. Stacy G.S., Nair L. Magnetic resonance imaging features of extremity sarcomas of uncertain differentiation. Clin Radiol 2007, 62(10):950-958.
48. Simmons M., Tucker A.K. The radiology of bone changes in rhabdomyosarcoma. Clin Radiol 1978, 29(1):47-52.
49. deSchepper A.M., Vanhoenacker F.M., Gielen L.M., et al. Imaging of soft tissue tumors 2006, Springer-Verlag, Berlin (Germany). 3rd edition.
50. Kindblom L.G., Angervall L., Svendsen P. Liposarcoma a clinicopathologic, radiographic and prognostic study. Acta Pathol Microbiol Scand Suppl 1975, (253):1-71.
51. Murphey M.D., Arcara L.K., Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics 2005, 25(5):1371-1395.
52. Mentzel T., Fletcher C.D. Lipomatous tumours of soft tissues: an update. Virchows Arch 1995, 427(4):353-363.
53. Miettinen M. Diagnostic soft tissue pathology 2003, Churchhill Livingstone, New York.
54. Peterson J.J., Kransdorf M.J., Bancroft L.W., et al. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol 2003, 32(9):493-503.
55. Ohguri T., Aoki T., Hisaoka M., et al. Differential diagnosis of benign peripheral lipoma from well-differentiated liposarcoma on MR imaging: is comparison of margins and internal characteristics useful?. AJR Am J Roentgenol 2003, 180(6):1689-1694.
56. Hosono M., Kobayashi H., Fujimoto R., et al. Septum-like structures in lipoma and liposarcoma: MR imaging and pathologic correlation. Skeletal Radiol 1997, 26(3):150-154.
57. Arkun R., Memis A., Akalin T., et al. Liposarcoma of soft tissue: MRI findings with pathologic correlation. Skeletal Radiol 1997, 26(3):167-172.
58. Kransdorf M.J., Bancroft L.W., Peterson J.J., et al. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology 2002, 224(1):99-104.
59. Weiss S.W., Goldblum J.R., Enzinger F.M. Liposarcoma. Enzinger and Weiss' soft tissue tumors 2008, 477-516. Mosby Elsevier, Philadelphia. 5th edition. S.W. Weiss, J.R. Goldblum (Eds.).
60. Kilpatrick S.E., Doyon J., Choong P.F., et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996, 77(8):1450-1458.
61. Smith T.A., Easley K.A., Goldblum J.R. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996, 20(2):171-180.
62. Allen P.W. Myxoid tumors of soft tissues. Pathol Annu 1980, 15(Pt 1):133-192.
63. Pearlstone D.B., Pisters P.W., Bold R.J., et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999, 85(1):85-92.
64. Jelinek J.S., Kransdorf M.J., Shmookler B.M., et al. Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology 1993, 186(2):455-459.
65. Sung M.S., Kang H.S., Suh J.S., et al. Myxoid liposarcoma: appearance at MR imaging with histologic correlation. Radiographics 2000, 20(4):1007-1019.
66. Tateishi U., Hasegawa T., Beppu Y., et al. Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma. AJR Am J Roentgenol 2004, 182(3):725-731.
67. Weiss S.W., Goldblum J.R., Enzinger F.M. Enzinger and Weiss's soft tissue tumors 2001, Mosby, St Louis (MO). 4th edition.
68. Israels S.J., Chan H.S., Daneman A., et al. Synovial sarcoma in childhood. AJR Am J Roentgenol 1984, 142(4):803-806.
69. Ishida T., Iijima T., Moriyama S., et al. Intra-articular calcifying synovial sarcoma mimicking synovial chondromatosis. Skeletal Radiol 1996, 25(8):766-769.
70. Fletcher C., Unni K., Mertens F. World Health Organization Pathology and Genetics of tumors of soft tissue and bone 2002, IARC Press, Lyon (France).
71. Cadman N.L., Soule E.H., Kelly P.J. Synovial sarcoma; an analysis of 34 tumors. Cancer 1965, 18:613-627.
72. Murphey M.D., Gibson M.S., Jennings B.T., et al. From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 2006, 26(5):1543-1565.
73. Ryan J.R., Baker L.H., Benjamin R.S. The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group. Clin Orthop Relat Res 1982, (164):257-260.
74. Paulino A.C. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol 2004, 27(2):122-127.
75. Wright P.H., Sim F.H., Soule E.H., et al. Synovial sarcoma. J Bone Joint Surg Am 1982, 64(1):112-122.
76. Horowitz A.L., Resnick D., Watson R.C. The roentgen features of synovial sarcomas. Clin Radiol 1973, 24(4):481-484.
77. Jones B.C., Sundaram M., Kransdorf M.J. Synovial sarcoma: MR imaging findings in 34 patients. AJR Am J Roentgenol 1993, 161(4):827-830.
78. Weiss S.W., Goldblum J.R., Enzinger F.M. Malignant tumors of the peripheral nerves. Enzinger and Weiss' soft tissue tumors 2008, 903-944. Mosby Elsevier, Philadelphia. 5th edition. S.W. Weiss, J.R. Goldblum (Eds.).
79. Ducatman B.S., Scheithauer B.W., Piepgras D.G., et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986, 57(10):2006-2021.
80. Mann F.A., Murphy W.A., Totty W.G., et al. Magnetic resonance imaging of peripheral nerve sheath tumors. Assessment by numerical visual fuzzy cluster analysis. Invest Radiol 1990, 25(11):1238-1245.
81. Bredella M.A., Torriani M., Hornicek F., et al. Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol 2007, 189(4):928-935.
82. Cardona S., Schwarzbach M., Hinz U., et al. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol 2003, 29(6):536-541.
83. Ferner R.E., Golding J.F., Smith M., et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 2008, 19(2):390-394.
84. Brenner W., Friedrich R.E., Gawad K.A., et al. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging 2006, 33(4):428-432.
85. Enzinger F.M. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 1965, 18:1163-1174.
86. Chung E.B., Enzinger F.M. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983, 7(5):405-413.
87. De Beuckeleer L.H., De Schepper A.M., Vandevenne J.E., et al. MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol 2000, 29(4):187-195.
88. Miettinen M. Hemangioendotheliomas, angiosarcomas, and Kaposi's sarcoma. Modern soft tissue pathology: tumors and non-neoplastic conditions 2010, Cambridge University Press, Cambridge (NY), p. 617-59.
89. Weiss S.W., Goldblum J.R., Enzinger F.M. Hemangioendothelioma, vascular tumors of intermediate malignancy. Enzinger and Weiss' soft tissue tumors 2008, 681-732. Mosby Elsevier, Philadelphia. 5th edition. S.W. Weiss, J.R. Goldblum (Eds.).
90. Murphey M.D., Fairbairn K.J., Parman L.M., et al. From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics 1995, 15(4):893-917.
91. Enjoji M., Hashimoto H. Diagnosis of soft tissue sarcomas. Pathol Res Pract 1984, 178(3):215-226.
92. Brenton G.E., Johnson D.E., Eady J.L. Leiomyosarcoma of the hand and wrist. Report of two cases. J Bone Joint Surg Am 1986, 68(1):139-142.
93. Shmookler B.M., Lauer D.H. Retroperitoneal leiomyosarcoma. A clinicopathologic analysis of 36 cases. Am J Surg Pathol 1983, 7(3):269-280.
94. Wile A.G., Evans H.L., Romsdahl M.M. Leiomyosarcoma of soft tissue: a clinicopathologic study. Cancer 1981, 48(4):1022-1032.
95. Hartman D.S., Hayes W.S., Choyke P.L., et al. From the archives of the AFIP. Leiomyosarcoma of the retroperitoneum and inferior vena cava: radiologic-pathologic correlation. Radiographics 1992, 12(6):1203-1220.
96. Kevorkian J., Cento D.P. Leiomyosarcoma of large arteries and veins. Surgery 1973, 73(3):390-400.
97. Berlin O., Stener B., Kindblom L.G., et al. Leiomyosarcomas of venous origin in the extremities. A correlated clinical, roentgenologic, and morphologic study with diagnostic and surgical implications. Cancer 1984, 54(10):2147-2159.
98. Bush C.H., Reith J.D., Spanier S.S. Mineralization in musculoskeletal leiomyosarcoma: radiologic-pathologic correlation. AJR Am J Roentgenol 2003, 180(1):109-113.
99. Rouhani P., Fletcher C.D., Devesa S.S., et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer 2008, 113(3):616-627.